Morgan Stanley Upgrades Intercept Pharma, Maintains $100 Target
January 29, 2016 at 08:56 AM EST
Intercept Pharmaceuticals Inc (NASDAQ: ICPT) shares have declined 63.88 percent over the past six months, reaching a low of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.